A platform for CRISPRi-seq in Streptomyces albidoflavus
ABSTRACT Streptomyces produce a multitude of secondary metabolites, which have been exploited in drug discovery campaigns for more than three-quarters of a century. Our understanding of microbial physiology has been revolutionized by genome sequencing and large-scale functional studies. Technology f...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology
2026-02-01
|
| Серии: | mBio |
| Предметы: | |
| Online-ссылка: | https://journals.asm.org/doi/10.1128/mbio.03065-25 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|